Biogen reported $7.27B in Loan Capital for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Loan Capital Change
Acadia Pharmaceuticals ACAD:US $ 0M 0M
Acorda Therapeutics ACOR:US $ 168.37M 2.2M
Amgen AMGN:US $ 31129M 1766M
Bayer BAYN:GR € 37918M 4722M
Biogen BIIB:US $ 7269.2M 2M
Biomarin Pharmaceutical BMRN:US $ 1076.13M 3.02M
Bluebird Bio BLUE:US $ 0M 0M
Bristol Myers Squibb BMY:US $ 44505M 3831M
Eli Lilly And LLY:US $ 16199.6M 387M
Esperion Therapeutics ESPR:US $ 271.69M 92.33M
Gw Pharmaceuticals GWPH:US $ 14.16M 0.14M
Intercept Pharmaceuticals ICPT:US $ 568.11M 7.53M
Intra Cellular Therapies ITCI:US $ 0M 0M
Moderna Inc MRNA:US $ 138M 28.13M
Neurocrine Biosciences NBIX:US $ 322M 4.1M
Novartis NOVN:VX SF 27399M 579M
Ptc Therapeutics PTCT:US $ 1111.93M 120.99M
Puma Biotechnology PBYI:US $ 76.35M 7.68M
Regeneron Pharmaceuticals REGN:US $ 1978.9M 716.8M
Sangamo Biosciences SGMO:US $ 0M 0M
Sarepta Therapeutics SRPT:US $ 1091.11M 98.62M
Seattle Genetics SGEN:US $ 0M 0M
Teva Pharmaceutical TEVA:IT 22.29B 443M
Ultragenyx Pharmaceutical RARE:US $ 0M 0.7M
United Therapeutics UTHR:US $ 800M 0M
Vertex Pharmaceuticals VRTX:US $ 572.86M 33.81M